Division of Gastroenterology, Department of Medicine, University of Michigan, AnnArbor, MI, USA.
University of Michigan Crohn's and Colitis Program, University of Michigan, AnnArbor, MI, USA.
J Crohns Colitis. 2019 Jul 25;13(7):905-915. doi: 10.1093/ecco-jcc/jjz010.
Tumour necrosis factor [TNF]α- and IL-17A-producing T cells are implicated in Crohn's disease [CD]. Tissue-resident memory T [TRM] cells are tissue-restricted T cells that are regulated by PR zinc finger domain 1 [PRDM1], which has been implicated in pathogenic Th17 cell responses. TRM cells provide host defence but their role in CD is unknown. We thus examined CD4+ TRM cells in CD.
Colon samples were prospectively collected at endoscopy or surgery in CD and control subjects. Flow cytometry and ex vivo assays were performed to characterise CD4+ TRM cells.
CD4+ TRM cells are the most abundant memory T cell population and are the major T cell source of mucosal TNFα in CD. CD4+ TRM cells are expanded in CD and more avidly produce IL-17A and TNFα relative to control cells. There was a unique population of TNFα+IL-17A+ CD4+ TRM cells in CD which are largely absent in controls. PRDM1 was highly expressed by CD4+ TRM cells but not by other effector T cells. Suppression of PRDM1 was associated with impaired induction of IL17A and TNFA by CD4+ TRM cells.
CD4+ TRM cells are expanded in CD and are a major source of TNFα, suggesting that they are important in CD. PRDM1 is expressed by TRM cells and may regulate their function. Collectively, this argues for prospective studies tracking CD4+ TRM cells over the disease course.
肿瘤坏死因子[TNF]α和白细胞介素-17A 产生的 T 细胞与克罗恩病[CD]有关。组织驻留记忆 T [TRM]细胞是受 PR 锌指结构域 1 [PRDM1]调控的组织限制性 T 细胞,PRDM1 已被牵连到致病性 Th17 细胞反应中。TRM 细胞提供宿主防御,但它们在 CD 中的作用尚不清楚。因此,我们检查了 CD 中的 CD4+ TRM 细胞。
前瞻性地在 CD 和对照受试者的内镜或手术中收集结肠样本。通过流式细胞术和体外实验来鉴定 CD4+ TRM 细胞。
CD4+ TRM 细胞是最丰富的记忆 T 细胞群体,是 CD 中粘膜 TNFα的主要 T 细胞来源。CD4+ TRM 细胞在 CD 中扩增,并相对于对照细胞更强烈地产生 IL-17A 和 TNFα。在 CD 中存在一个独特的 TNFα+IL-17A+ CD4+ TRM 细胞群体,而在对照中则很少。PRDM1 被 CD4+ TRM 细胞高度表达,但不被其他效应 T 细胞表达。PRDM1 的抑制与 CD4+ TRM 细胞中 IL17A 和 TNFA 的诱导受损有关。
CD4+ TRM 细胞在 CD 中扩增,并是 TNFα的主要来源,表明它们在 CD 中很重要。PRDM1 由 TRM 细胞表达,可能调节其功能。总的来说,这支持了对 CD4+ TRM 细胞进行疾病过程跟踪的前瞻性研究。